• Je něco špatně v tomto záznamu ?

Aktualizované výsledky celkového prežitia z WJTOG 3405, randomizovanej štúdie fázy III porovnávajúcej gefitinib (G) s cisplatinou plus docetaxelom (CD) ako prvolíniovú liečbu pre pacientov s nemalobunkovým karcinómom pľúc s mutáciami receptoru epidermálneho rastového faktoru (EGFR)

Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, Shunichi Negoro, Isamu Okamoto, Takashi Seto, Miyako Satouchi, Hirohito Tada, Tomonori Hirashima, Kazuhiro Asami, Nobuyuki Katakami, Minoru Takada, Hiroshige Yoshioka, Kazuhiko Shibata, Shinzoh...

. 2012 ; 4 (Speciální číslo) : 134-135.
. 2012 ; 4 (Speciální číslo) : 134-135.

Status neindexováno Jazyk slovenština Země Česko

Typ dokumentu abstrakt z konference

Perzistentní odkaz   https://www.medvik.cz/link/bmc13013576

Cancer Center Izumi Municipal Hospital Osaka Japan

Clinical Research Center Division of Pulmonary Medicine Kobe City Medical Center General Hospital Kobe Japan

Department of Biostatistics and Epidemiology Yokohama City University Medical Center Yokohama Japan

Department of Cancer and Thoracic Surgery Graduate School of Medicine Dentistry and Pharmaceutical Sciences Okayama University Okayama Japan

Department of General Thoracic Surgery Osaka City General Hospital Osaka Japan

Department of Medical Oncology Kinki University School of Medicine Osaka Japan

Department of Medical Oncology Koseiren Takaoka Hospital Takaoka Japan

Department of Medical Oncology Sakai Hospital Kinki University School of Medicine Osaka Japan

Department of Pathology and Molecular Diagnostics Aichi Cancer Center Hospital Nagoya Japan

Department of Respiratory Medicine Aichi Cancer Center Aichi Hospital Okazaki Japan

Department of Respiratory Medicine Kinki Chuo Chest Medical Center Sakai Japan

Department of Respiratory Medicine Kurashiki Central Hospital Kurashiki Japan

Department of Respiratory Medicine Osaka City University Medical School Osaka Japan

Department of Thoracic Oncology Hyogo Cancer Center Akashi Hyogo Japan

Department of Thoracic Oncology National Kyushu Cancer Center Fukuoka Japan

Department of Thoracic Oncology Osaka Prefectual Medical Center for Respiratory and Allergic Diseases Osaka Japan

Department of Thoracic Surgery Aichi Cancer Center Hospital Nagoya Japan

Division of Medical Oncology and Molecular Respirology Tottori University Tottori Japan

Medical Oncology Division Hyogo Cancer Center Akashi Japan

Vybraná abstrakta ze 48. výročního zasedání 1.-5. června 2012 McCormick Place Chigaco, IL, USA

000      
00000naa a2200000 a 4500
001      
bmc13013576
003      
CZ-PrNML
005      
20170309104957.0
007      
ta
008      
130410s2012 xr f 00 0slo||
009      
PC
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a slo
044    __
$a xr
100    1_
$a Mitsudomi, Tetsuya $u Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
245    10
$a Aktualizované výsledky celkového prežitia z WJTOG 3405, randomizovanej štúdie fázy III porovnávajúcej gefitinib (G) s cisplatinou plus docetaxelom (CD) ako prvolíniovú liečbu pre pacientov s nemalobunkovým karcinómom pľúc s mutáciami receptoru epidermálneho rastového faktoru (EGFR) / $c Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, Shunichi Negoro, Isamu Okamoto, Takashi Seto, Miyako Satouchi, Hirohito Tada, Tomonori Hirashima, Kazuhiro Asami, Nobuyuki Katakami, Minoru Takada, Hiroshige Yoshioka, Kazuhiko Shibata, Shinzoh Kudoh, Eiji Shimizu, Hiroshi Saito, Shinichi Toyooka, Kazuhiko Nakagawa, Masahiro Fukuoka, West Japan Oncology Group
500    __
$a Vybraná abstrakta ze 48. výročního zasedání 1.-5. června 2012 McCormick Place Chigaco, IL, USA
590    __
$a NEINDEXOVÁNO
655    _2
$a abstrakt z konference $7 D016416
700    1_
$a Morita, Satoshi $u Department of Biostatistics and Epidemiology, Yokohama City University Medical Center, Yokohama, Japan
700    1_
$a Yatabe, Yasushi $u Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan
700    1_
$a Negoro, Shunichi $u Medical Oncology Division, Hyogo Cancer Center, Akashi, Japan
700    1_
$a Okamoto, Isamu $u Department of Medical Oncology, Kinki University School of Medicine, Osaka, Japan
700    1_
$a Seto, Takashi $u Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
700    1_
$a Satouchi, Miyako $u Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan
700    1_
$a Tada, Hirohito $u Department of General Thoracic Surgery, Osaka City General Hospital, Osaka, Japan
700    1_
$a Hirashima, Tomonori $u Department of Thoracic Oncology, Osaka Prefectual Medical Center for Respiratory and Allergic Diseases, Osaka, Japan
700    1_
$a Asami, Kazuhiro $u Department of Respiratory Medicine, Kinki-Chuo Chest Medical Center, Sakai, Japan $7 gn_A_00009171
700    1_
$a Katakami, Nobuyuki $u Clinical Research Center, Division of Pulmonary Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
700    1_
$a Takada, Minoru $u Department of Medical Oncology, Sakai Hospital Kinki University School of Medicine, Osaka, Japan
700    1_
$a Yoshioka, Hiroshige $u Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan
700    1_
$a Shibata, Kazuhiko $u Department of Medical Oncology, Koseiren Takaoka Hospital, Takaoka, Japan
700    1_
$a Kudoh, Shinzoh $u Department of Respiratory Medicine, Osaka City University Medical School, Osaka, Japan
700    1_
$a Shimizu, Eiji $u Division of Medical Oncology and Molecular Respirology, Tottori University, Tottori, Japan
700    1_
$a Saito, Hiroshi $u Department of Respiratory Medicine, Aichi Cancer Center, Aichi Hospital, Okazaki, Japan
700    1_
$a Toyooka, Shinichi $u Department of Cancer and Thoracic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
700    1_
$a Nakagawa, Kazuhiko $u Cancer Center, Izumi Municipal Hospital, Osaka, Japan
700    1_
$a Fukuoka, Masahiro $u Cancer Center, Izumi Municipal Hospital, Osaka, Japan
773    0_
$t Journal of clinical oncology $x 1803-8506 $g Roč. 4, Speciální číslo (2012), s. 134-135 $w MED00164415
773    0_
$t ASCO Annual Meeting $x 1803-8506 $g Roč. 4, Speciální číslo (2012), s. 134-135 $w MED00180949
856    41
$u http://www.tribune.cz/tituly/jco/archiv/479 $y domovská stránka časopisu - plný text volně přístupný
910    __
$a ABA008 $b B 2589 $c 655 a $y 3 $z 0
990    __
$a 20130326150227 $b ABA008
991    __
$a 20170309105212 $b ABA008
999    __
$a ok $b bmc $g 976702 $s 811868
BAS    __
$a 6
BMC    __
$a 2012 $b 4 $c Speciální číslo $d 134-135 $i 1803-8506 $m Journal of Clinical Oncology (České vyd.) $n J. clin. Oncol. (Čes. vyd.) $x MED00164415
BMC    __
$a 2012 $b 4 $c Speciální číslo $d 134-135 $i 1803-8506 $m ASCO Annual Meeting $x MED00180949
LZP    __
$a NLK 2013-05/mkbi

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...